Human phosphoribosylpyrophosphate synthetase. Comparison of purified normal and mutant enzymes
- PMID: 169259
Human phosphoribosylpyrophosphate synthetase. Comparison of purified normal and mutant enzymes
Abstract
Human phosphoribosylpyrophosphate synthetase has been purified 4500-fold to electrophoretic homogeneity from the erythrocytes of normal individuals and of two brothers in whom excessive activity of this enzyme results in excessive rated of purine nucleotide and uric acid synthesis de novo and gouty arthritis. Structural differences between the normal and mutant enzymes are indicated by a lower isoelectric point for the mutant enzyme (pI 4.85) than for the normal enzyme (pI 5.10); decreased electrophoretic mobility of the mutant preparation on cellulose acetate gel at low inorganic phosphate concentrations; increased (2.4-fold) inactivation of the mutant enzyme activity relative to the normal by identical amounts of a specific antiserum which precipitates identical quantities of normal and mutant enzyme; increased thermal lability of the mutant enzyme at 55 degrees; and an increased (2.2-fold) specific enzyme activity for the mutant enzyme despite the comparable purity of the preparations. Antibody inactivation, quantitative precipitin, and immunodiffusion studies as well as the disparity in specific enzyme activities during the course of purification suggest that a structural alteration in the mutant enzyme leads to increased catalytic activity per enzyme molecule, either from a primary alteration in the structural gene(s) for phosphoribosylpyrophosphate synthetase or from a post-transcriptional alteration in the enzyme. Purified preparations of normal and mutant enzymes showed nearly identical affinity constants for magnesium and the substrates, ATP and ribose 5-phosphate, as well as similar inhibition constants for the products, PP-ribose-P and AMP, and the inhibitors ADP, GDP, and 2,3-diphosphoglycerate. An increased maximal velocity of the reaction was, thus, the sole kinetic difference identified. The increased velocity of the mutant enzyme reaction was constant over a range of inorganic phosphate concentrations from 0.1 to 100 mM. Subunit molecular weights of the enzyme preparations, estimated by sodium dodecyl sulfate-polyacrylamide electrophoresis, were identical (32,000), although the undenatured mutant enzyme showed a greater proportion of stainable protein in the smaller of two molecular weight forms (both greater than 500,000) of the enzyme demonstrated on polyacrylamide gel electrophoresis in the presence of 1 mM sodium phosphate.
Similar articles
-
Variant human phosphoribosylpyrophosphate synthetase altered in regulatory and catalytic functions.J Clin Invest. 1980 Jan;65(1):109-20. doi: 10.1172/JCI109640. J Clin Invest. 1980. PMID: 6243137 Free PMC article.
-
Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.J Lab Clin Med. 1982 Apr;99(4):495-511. J Lab Clin Med. 1982. PMID: 6174658
-
A gouty family with increased phosphoribosylpyrophosphate synthetase activity: case reports, familial studies, and kinetic studies of the abnormal enzyme.J Rheumatol. 1981 Jul-Aug;8(4):563-74. J Rheumatol. 1981. PMID: 6271966
-
Human phosphoribosylpyrophosphate (PRPP) synthetase requirements for subunit aggregation.Adv Exp Med Biol. 1984;165 Pt A:427-32. doi: 10.1007/978-1-4684-4553-4_84. Adv Exp Med Biol. 1984. PMID: 6326486 No abstract available.
-
Diagnostic evaluation of phosphoribosylpyrophosphate synthetase activities in hemolysates.J Lab Clin Med. 1984 Jun;103(6):932-43. J Lab Clin Med. 1984. PMID: 6327865
Cited by
-
PRPS1 mutations: four distinct syndromes and potential treatment.Am J Hum Genet. 2010 Apr 9;86(4):506-18. doi: 10.1016/j.ajhg.2010.02.024. Am J Hum Genet. 2010. PMID: 20380929 Free PMC article. Review.
-
Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel allosteric site.Biochem J. 2007 Jan 1;401(1):39-47. doi: 10.1042/BJ20061066. Biochem J. 2007. PMID: 16939420 Free PMC article.
-
Human skin collagenase in recessive dystrophic epidermolysis bullosa. Purification of a mutant enzyme from fibroblast cultures.J Clin Invest. 1982 Jun;69(6):1373-83. doi: 10.1172/jci110577. J Clin Invest. 1982. PMID: 6282934 Free PMC article.
-
Association of PRPS1 Mutations with Disease Phenotypes.Dis Markers. 2015;2015:127013. doi: 10.1155/2015/127013. Epub 2015 May 24. Dis Markers. 2015. PMID: 26089585 Free PMC article. Review.
-
The mode of genetic transmission of gouty family with increased phosphoribosylpyrophosphate synthetase activity.Hum Genet. 1981;58(3):322-30. doi: 10.1007/BF00294932. Hum Genet. 1981. PMID: 6276287
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous